awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38771802-234854C5-83E7-4D7E-A937-71B48B4969DE
Q38771802-234854C5-83E7-4D7E-A937-71B48B4969DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38771802-234854C5-83E7-4D7E-A937-71B48B4969DE
Combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells
P2860
Q38771802-234854C5-83E7-4D7E-A937-71B48B4969DE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38771802-234854C5-83E7-4D7E-A937-71B48B4969DE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc9ff8b1776068c7ee0c5d2a349c1f09b4324df9
P2860
Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.